Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#1033
Protagonist Therapeutics, Inc
92.080
0
+6.88%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+6.88%
Monthly Change
+11.68%
6 month change
+22.56%
Year Change
+22.56%
Previous Close
86.150
0
Open
92.210
0
Bid
Ask
Low
92.080
0
High
92.220
0
Volume
152
Markets
US Stock Market
Healthcare
PTGX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Protagonist Therapeutics director Williams sells $1.48 million in shares
Protagonist Therapeutics director sells $1.67 million in shares
Top Biotech Stocks to Watch in 2026, According to Truist
Protagonist Therapeutics stock price target raised to $117 from $80 at H.C. Wainwright
Protagonist Stock: Assessing The 2026 Upside For Icotrokinra And Rusfertide (PTGX)
Ali Asif, CFO of protagonist, sells $3.8m in PTGX stock
Protagonist Therapeutics CEO Patel sells $4m in shares
Protagonist Therapeutics chief medical officer sells $1.9m in shares
JPMorgan reiterates Overweight rating on Protagonist Therapeutics stock
Wednesday’s Insider Activity: Top Buys and Sells for January 21